×
Back to Agenda
More Nuanced Clinical Outcomes from Person-Generated Health Data: The New Frontier
Session Chair(s)
Nancy Dreyer, MPH, FISPE
Founder
Dreyer Strategies LLC, United States
Person-generated data offers nuanced effectiveness measures for clinical and regulatory decision-making for new medical products, like the wearable-derived digital clinical outcome assessment for Duchenne muscular dystrophy. What's next?
Learning Objective : Describe practical applications of person-generated health data, and key business and regulatory perspectives on opportunities and challenges; Explain the value of this type of information to patients, clinicians, and colleagues to help inform decision-making.
Speaker(s)
Panelist
Christina Mack, MPH
IQVIA, United States
CSO RWE and SVP AAIS
Panelist
Jeffrey Nahum Siegel, DrMed, MD
FDA, United States
Director, Office of Drug Evaluation Sciences, OND, CDER
Panelist
Martha Azer, PHARMD, RPH
Johnson & Johnson, United States
Associate Director, Global Regulatory Policy & Intelligence
Have an account?